ATE344327T1 - Regulation der ausschleusung von proteinen - Google Patents

Regulation der ausschleusung von proteinen

Info

Publication number
ATE344327T1
ATE344327T1 AT98941592T AT98941592T ATE344327T1 AT E344327 T1 ATE344327 T1 AT E344327T1 AT 98941592 T AT98941592 T AT 98941592T AT 98941592 T AT98941592 T AT 98941592T AT E344327 T1 ATE344327 T1 AT E344327T1
Authority
AT
Austria
Prior art keywords
proteins
normally
mammalian
secreted
exclusion
Prior art date
Application number
AT98941592T
Other languages
English (en)
Inventor
Albert Tauler
Ian Fraser Pryme
John Edward Hesketh
Original Assignee
Uni Targeting Res As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Targeting Res As filed Critical Uni Targeting Res As
Application granted granted Critical
Publication of ATE344327T1 publication Critical patent/ATE344327T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98941592T 1997-09-05 1998-09-04 Regulation der ausschleusung von proteinen ATE344327T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9718908.8A GB9718908D0 (en) 1997-09-05 1997-09-05 Proteins

Publications (1)

Publication Number Publication Date
ATE344327T1 true ATE344327T1 (de) 2006-11-15

Family

ID=10818638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98941592T ATE344327T1 (de) 1997-09-05 1998-09-04 Regulation der ausschleusung von proteinen

Country Status (10)

Country Link
US (1) US6881832B1 (de)
EP (1) EP1009834B1 (de)
JP (1) JP4436563B2 (de)
AT (1) ATE344327T1 (de)
AU (1) AU8991098A (de)
DE (1) DE69836336T2 (de)
DK (1) DK1009834T3 (de)
ES (1) ES2273435T3 (de)
GB (1) GB9718908D0 (de)
WO (1) WO1999013090A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004094592A2 (en) * 2003-04-18 2004-11-04 Biogen Idec Ma Inc. Polymer-conjugated glycosylated neublastin
GB0314856D0 (en) 2003-06-25 2003-07-30 Unitargeting Res As Protein expression system
US7598059B2 (en) 2003-10-02 2009-10-06 Biogen Idec Ma Inc. Neublastin expression constructs
CA2577690C (en) 2004-08-19 2013-08-06 Biogen Idec Ma Inc. Refolding transforming growth factor beta family proteins
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
US20090075925A1 (en) * 2006-11-16 2009-03-19 Smith Harold C Methods and Compositions Related to APOBEC-1 Expression
EP2142205B1 (de) 2007-05-01 2014-04-02 Biogen Idec MA Inc. Neublastin Peptide für erhöhte Vaskularisierung im Gewebe mit reduzierter Durchblutung
SG11201405542UA (en) * 2012-03-27 2014-10-30 Curevac Gmbh Artificial nucleic acid molecules
WO2013151665A2 (en) * 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins associated with human disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3540505C2 (de) 1985-11-15 1995-11-09 Natronag Verpackung Sackfüllmaschine
AU613876B2 (en) * 1986-10-01 1991-08-15 Merck & Co., Inc. Synthetic genes encoding proteins from plasmid containing eucaryotic secretory signal peptides and process for secreting encoded proteins
EP0832981A1 (de) * 1987-02-17 1998-04-01 Pharming B.V. DNA-Sequenzen die Proteine zwecks effizienter Abscheidung zur Milchdrüse leiten
FI914947A0 (fi) * 1990-02-22 1991-10-21 Biogen Inc Foerbaettrad expression av polypeptider.
AU663101B2 (en) * 1991-08-13 1995-09-28 Wisconsin Milk Marketing Board DNA sequence encoding bovine alpha-lactalbumin and methods of use

Also Published As

Publication number Publication date
DE69836336T2 (de) 2007-05-24
JP4436563B2 (ja) 2010-03-24
ES2273435T3 (es) 2007-05-01
DE69836336D1 (de) 2006-12-14
JP2001515725A (ja) 2001-09-25
AU8991098A (en) 1999-03-29
EP1009834B1 (de) 2006-11-02
GB9718908D0 (en) 1997-11-12
DK1009834T3 (da) 2007-02-12
WO1999013090A1 (en) 1999-03-18
US6881832B1 (en) 2005-04-19
EP1009834A1 (de) 2000-06-21

Similar Documents

Publication Publication Date Title
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
DE69832293D1 (de) Zubereitungen zur abgabe von negativ geladenen molekülen
ATE227739T1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
NO990086L (no) Avkortete, l°selige tumornekrosefaktorreseptorer av type I og type II
DE3382390D1 (de) Zellinien und ihre verwendung in der herstellung von proteinen.
TR199900624T2 (xx) Proteinlerin y�ksek seviyede ekspresyonu.
DE69033735D1 (de) Varianten von adhäsionsmoleküle für blutplättchen
DE69515898D1 (de) 6-ARYL-PYRIDO[2,3-d]PYRIMIDINE UND -NAPHTHYRIDINE ZUR HEMMUNG DER DURCH PROTEIN-TYROSIN-KINASE HERVORGERUFENEN ZELLVERMEHRUNG
TR200000654T2 (tr) KAY-Yeni bir bağışıklık sistemi proteini.
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
ATE335078T1 (de) Überexpression von säugetier- und virusproteinen
NO965362L (no) Syntetiske lederpeptidsekvenser
DE69707903D1 (de) Verwendung von zirkulatoren in zeitduplex-funksystemen
GB2331753A (en) Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
DE69630955T2 (de) Immortalisierung bzw. desimmortalisierung von zellen
EA199900869A1 (ru) Цитокин-подобный фактор 7 млекопитающих
ATE344327T1 (de) Regulation der ausschleusung von proteinen
DE69001609D1 (de) Herstellung von niedrigviskosen fotografischen kleinteilchen-dispersionen in gelatine.
DE69631972D1 (de) Proliferationsinhibitor von endothellzellen und dessen verwendung
DE59508100D1 (de) Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
DE69903559D1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
WO2000018909A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM)
ES2052513T3 (es) Nuevos polipeptidos, su fabricacion y empleo.
CA2146240A1 (en) Increased production of secreted proteins by recombinant eukaryotic cells

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1009834

Country of ref document: EP